Skip to content

Rehabilitative BCI in Acute Ischemic Stroke

Rehabilitative BCI for Lower Limb Function Recovery in Acute Ischemic Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04704427
Enrollment
40
Registered
2021-01-11
Start date
2021-01-16
Completion date
2021-12-31
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Keywords

Brain Computer Interface, Lower Limb Function Recovery, Brain Machine Interface

Brief summary

In order to explore the role and expound the mechanism of rehabilitative brain computer interface (BCI)-based training (referred to as the Walk Again Neurorehabilitation protocol) in neurofunctional reconstruction in acute phase of cerebral infarction, the investigators choose non-invasive BCI to study lower limb function of patients with acute cerebral infarction. The investigators evaluate lower limb function, the influence on the central brain functional network and relevant immuno-inflammatory indicators, so that the investigators can explore the therapeutic effect and mechanism in the acute phase of cerebral infarction and provide theoretical bases and feasible guidances for the treatment of post-stroke dyskinesia.

Detailed description

The participants will be randomly divided into experimental group and control group. The experimental group will receive BCI-based lower limb functional training, 30 minutes per time, 5 times per week, with a 4-week training period; the control group will only receive routine lower limb training, with the same treatment frequency, intensity and duration. Statistical analysis will be performed to compare the relevant evaluation indexes of the experimental group and the control group after treatment and 90 days. In this study, the investigators will use Lower Extremity Fugl-Meyer Assessment (LE-FMA) to comprehensively evaluate the function of lower limbs, Functional Ambulation Category Scale (FAC) and 10-meter walking test (10MWT) for walking ability, modified Barthel index (MBI) for daily living abilities, functional magnetic resonance imaging(fMRI)and near infrared functional brain imaging (NIRS) to evaluate brain function and network reconstruction, the translocator protein(TSPO)-positron emission tomography (PET) and blood immune inflammation indicators to evaluate systemic and intracranial immune status.

Interventions

DEVICENon-invasive BCI training

In the experimental group, the participants receive non-invasive rehabilitative BCI training. The training using the lower limb orthosis targeted the patient's ability to walk.

OTHERTraditional Physiotherapy protocol

In the control group,the participants receive the traditional physiotherapy protocol, including muscle strength training, balance training and walking training, etc.

Sponsors

Xuanwu Hospital, Beijing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. The diagnosis of cerebral infarction conforms to the diagnostic criteria of Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018. 2. 35 ≤ age ≤ 60 . 3. Onset (last-seen-well) time to randomization time from 24-72 hours. 4. First onset. 5. The lesion is assessed by MRI as a single subcortical infarction of the anterior circulation. 6. 5 ≤NIHSS≤15 (and 1 ≤6a/b≤3 ). 7. 1 ≤FAC functional walking scale score ≤ 3. 8. Signed informed consent from subject or legally authorized representative.

Exclusion criteria

1. Unstable vital signs. 2. Progressive stroke. 3. Patients have received intravenous thrombolysis or endovascular treatment. 4. Cardiogenic cerebral embolism. 5. Presence of moderate or higher vascular stenosis or vulnerable plaque based on Imaging assessment. 6. With other diseases of the nervous system. 7. With serious diseases of other systems (severe circulatory system, respiratory system, motor system) and other diseases unsuitable for training, such as atrial fibrillation, heart failure, lung infection, severe liver or kidney insufficiency, lower extremity venous thrombosis. 8. Lower limb dysfunction caused by other reasons, such as fracture, lower limb deformity, etc. 9. With contraindications in imaging examinations, such as metal implantation, fear of claustrophobia, and severe obesity. 10. Patient who cannot cooperate with training, such as mental disorders, cognitive dysfunction, Mini-Mental State Examination (MMSE) \<21 points, etc. 11. Other reasons: alcoholism; pregnancy; skull defect; indwelling urinary catheter; vision defects affect training, etc.

Design outcomes

Primary

MeasureTime frameDescription
Change in Fugl-Meyer score of lower limbs from baseline to 4 weeks.0-4 weeks.It consists of 17 individual assessments that are summed to generate a total score. Scores range from 0-34, the higher the better.

Secondary

MeasureTime frameDescription
10-meter walk test4 weeks and 90 days.Gait speed will be measured as the average of 3 times 10-meter walk tests. Participants will be asked to walk at their normal comfortable pace (handheld assistive device is acceptable if needed).
Modified Barthel index4 weeks and 90 days.Scale range: 0-100 (with higher scores indicating a greater ability to complete activities of daily living)
National Institutes of Health Stroke Scale4 weeks and 90 days.The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. The range of scores is from 0 (normal) to 42, with higher scores indicating greater stroke severity.
Gait analysis ( stride frequency, step length and velocity)4 weeks and 90 days.To evaluate the walking ability
Functional ambulation category scale4 weeks and 90 days.This scale indicates the ability to walk independently and serves as the primary outcome measure.Participants will be asked to walk at their normal comfortable pace (handheld assistive device is acceptable if needed).
Changes in oxyhaemoglobin in related cortex by Functional near-infrared spectroscopy4 weeks and 90 days.To evaluate the brain cortex function.
The translocator protein(TSPO)-positron emission tomography (PET)4 weeks.Respond to inflammation in the brain
Fugl-Meyer score of lower limbs90 days.It consists of 17 individual assessments that are summed to generate a total score. Scores range from 0-34, the higher the better.
Nodal functional connectivity strength analysis by functional magnetic resonance imaging4 weeks and 90 days.To evaluate the brain function and network

Contacts

Primary ContactJunwei Hao, MD,PHD
haojunwei@vip.163.com010-83199088
Backup ContactHaijie Liu, MD,PHD
haijieliu@163.com+8615822841534

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026